Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.
Learn how Novartis researchers are working to outsmart tumors.
Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.
Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.
An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.
Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.
Elyse Spatz Caplan’s cancer diagnosis impacted her life in more ways than 1